 Danielle Cooke
Concepts (466)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Arteriovenous Malformations | 26 | 2022 | 51 | 6.140 |
Why?
| | Embolization, Therapeutic | 28 | 2023 | 178 | 5.920 |
Why?
| | Intracranial Aneurysm | 20 | 2022 | 90 | 5.520 |
Why?
| | Endovascular Procedures | 22 | 2022 | 267 | 4.400 |
Why?
| | Endothelial Cells | 8 | 2022 | 677 | 2.420 |
Why?
| | Subarachnoid Hemorrhage | 10 | 2022 | 60 | 2.410 |
Why?
| | Cerebral Angiography | 24 | 2024 | 108 | 2.350 |
Why?
| | Stents | 11 | 2022 | 466 | 2.210 |
Why?
| | Central Nervous System Vascular Malformations | 11 | 2022 | 23 | 2.160 |
Why?
| | Stroke | 19 | 2023 | 1019 | 2.140 |
Why?
| | Biopsy | 7 | 2022 | 1024 | 2.100 |
Why?
| | Angiography, Digital Subtraction | 16 | 2022 | 44 | 1.880 |
Why?
| | Aneurysm, Ruptured | 7 | 2022 | 34 | 1.850 |
Why?
| | Tomography, X-Ray Computed | 18 | 2022 | 2272 | 1.600 |
Why?
| | Arteriovenous Fistula | 7 | 2021 | 29 | 1.550 |
Why?
| | Robotics | 3 | 2024 | 76 | 1.520 |
Why?
| | Brain Ischemia | 10 | 2022 | 297 | 1.230 |
Why?
| | Intracranial Hemorrhages | 7 | 2022 | 76 | 1.210 |
Why?
| | Basilar Artery | 2 | 2018 | 6 | 1.190 |
Why?
| | Retinoblastoma | 5 | 2023 | 27 | 1.150 |
Why?
| | Feasibility Studies | 6 | 2022 | 735 | 1.120 |
Why?
| | Retinal Neoplasms | 4 | 2018 | 21 | 1.100 |
Why?
| | Fluoroscopy | 8 | 2018 | 139 | 1.100 |
Why?
| | Vasospasm, Intracranial | 6 | 2017 | 17 | 1.090 |
Why?
| | Humans | 134 | 2024 | 114045 | 0.940 |
Why?
| | Neurosurgery | 2 | 2022 | 26 | 0.940 |
Why?
| | Magnetic Resonance Imaging | 19 | 2021 | 3039 | 0.920 |
Why?
| | Iliac Artery | 2 | 2014 | 44 | 0.910 |
Why?
| | Phantoms, Imaging | 6 | 2018 | 123 | 0.890 |
Why?
| | Software | 4 | 2020 | 526 | 0.870 |
Why?
| | Radiography, Interventional | 5 | 2023 | 105 | 0.870 |
Why?
| | Magnetic Resonance Imaging, Interventional | 6 | 2016 | 20 | 0.860 |
Why?
| | Endothelium, Vascular | 3 | 2019 | 830 | 0.850 |
Why?
| | Radiosurgery | 8 | 2022 | 299 | 0.850 |
Why?
| | Vascular Malformations | 5 | 2022 | 48 | 0.840 |
Why?
| | Retrospective Studies | 54 | 2024 | 12521 | 0.840 |
Why?
| | Thrombectomy | 8 | 2022 | 52 | 0.830 |
Why?
| | Cerebral Hemorrhage | 7 | 2022 | 96 | 0.830 |
Why?
| | Stroke Rehabilitation | 1 | 2023 | 34 | 0.810 |
Why?
| | Aneurysm | 3 | 2021 | 29 | 0.810 |
Why?
| | Middle Aged | 55 | 2024 | 26605 | 0.790 |
Why?
| | Brain | 15 | 2022 | 2355 | 0.770 |
Why?
| | Carotid Stenosis | 1 | 2022 | 79 | 0.740 |
Why?
| | Male | 73 | 2024 | 55396 | 0.740 |
Why?
| | Cerebral Arteries | 4 | 2017 | 55 | 0.720 |
Why?
| | Magnetic Resonance Angiography | 6 | 2020 | 221 | 0.720 |
Why?
| | Balloon Occlusion | 1 | 2020 | 23 | 0.710 |
Why?
| | Central Nervous System Diseases | 1 | 2021 | 60 | 0.690 |
Why?
| | Veins | 3 | 2022 | 55 | 0.680 |
Why?
| | Vascular Access Devices | 3 | 2018 | 24 | 0.680 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 86 | 0.680 |
Why?
| | Treatment Outcome | 32 | 2023 | 9049 | 0.670 |
Why?
| | Carotid Artery, Common | 1 | 2020 | 29 | 0.670 |
Why?
| | Cerebral Veins | 3 | 2021 | 15 | 0.660 |
Why?
| | Melphalan | 3 | 2018 | 29 | 0.640 |
Why?
| | Catheterization, Peripheral | 3 | 2016 | 100 | 0.640 |
Why?
| | Needles | 2 | 2018 | 49 | 0.630 |
Why?
| | Female | 71 | 2024 | 59324 | 0.610 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 15 | 0.610 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2022 | 395 | 0.610 |
Why?
| | Aged | 41 | 2024 | 18969 | 0.610 |
Why?
| | Graft Occlusion, Vascular | 1 | 2018 | 35 | 0.610 |
Why?
| | Wounds, Stab | 1 | 2018 | 11 | 0.600 |
Why?
| | Jugular Veins | 1 | 2018 | 38 | 0.590 |
Why?
| | Neck Injuries | 1 | 2018 | 17 | 0.580 |
Why?
| | Nerve Net | 5 | 2020 | 227 | 0.580 |
Why?
| | Aorta, Thoracic | 1 | 2020 | 257 | 0.570 |
Why?
| | Lymphatic Abnormalities | 3 | 2022 | 18 | 0.550 |
Why?
| | Adult | 43 | 2024 | 30375 | 0.530 |
Why?
| | Angioplasty | 3 | 2022 | 40 | 0.500 |
Why?
| | Neuroimaging | 5 | 2020 | 249 | 0.500 |
Why?
| | Disease Management | 3 | 2017 | 556 | 0.490 |
Why?
| | Orbital Diseases | 2 | 2018 | 24 | 0.490 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2015 | 7 | 0.490 |
Why?
| | Renal Dialysis | 1 | 2018 | 375 | 0.470 |
Why?
| | Tissue and Organ Harvesting | 1 | 2015 | 62 | 0.470 |
Why?
| | Neural Pathways | 4 | 2020 | 260 | 0.460 |
Why?
| | Deep Brain Stimulation | 1 | 2015 | 72 | 0.450 |
Why?
| | Magnetic Fields | 2 | 2014 | 22 | 0.450 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2020 | 224 | 0.450 |
Why?
| | Cell Separation | 1 | 2013 | 290 | 0.410 |
Why?
| | Transcranial Magnetic Stimulation | 3 | 2020 | 44 | 0.410 |
Why?
| | Spinal Cord | 3 | 2023 | 344 | 0.410 |
Why?
| | Mammary Arteries | 1 | 2012 | 6 | 0.400 |
Why?
| | Infusions, Intra-Arterial | 6 | 2018 | 46 | 0.400 |
Why?
| | Blood Vessel Prosthesis | 3 | 2019 | 113 | 0.400 |
Why?
| | Clinical Protocols | 3 | 2018 | 232 | 0.400 |
Why?
| | Vertebral Artery Dissection | 1 | 2012 | 18 | 0.400 |
Why?
| | Infarction, Middle Cerebral Artery | 2 | 2013 | 35 | 0.400 |
Why?
| | Catheters | 4 | 2017 | 64 | 0.390 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 228 | 0.380 |
Why?
| | Sclerotherapy | 4 | 2022 | 18 | 0.380 |
Why?
| | Transcriptome | 3 | 2022 | 723 | 0.380 |
Why?
| | Atherosclerosis | 1 | 2015 | 342 | 0.370 |
Why?
| | Radial Artery | 2 | 2021 | 66 | 0.370 |
Why?
| | Temporal Arteries | 1 | 2011 | 47 | 0.360 |
Why?
| | Carotid Artery, Internal | 4 | 2019 | 36 | 0.360 |
Why?
| | Obsessive-Compulsive Disorder | 2 | 2022 | 32 | 0.350 |
Why?
| | Neuronavigation | 1 | 2010 | 5 | 0.350 |
Why?
| | Surgical Instruments | 1 | 2010 | 48 | 0.340 |
Why?
| | Ultrasonography, Doppler, Transcranial | 4 | 2017 | 42 | 0.340 |
Why?
| | Arteriovenous Malformations | 2 | 2020 | 24 | 0.330 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 271 | 0.330 |
Why?
| | Carotid-Cavernous Sinus Fistula | 2 | 2019 | 7 | 0.320 |
Why?
| | Cardiac Catheterization | 1 | 2013 | 545 | 0.320 |
Why?
| | Aged, 80 and over | 12 | 2022 | 6306 | 0.310 |
Why?
| | Connectome | 5 | 2020 | 63 | 0.310 |
Why?
| | Cerebrovascular Circulation | 5 | 2022 | 219 | 0.310 |
Why?
| | Vasodilator Agents | 1 | 2010 | 302 | 0.300 |
Why?
| | Contrast Media | 4 | 2020 | 347 | 0.300 |
Why?
| | Magnetics | 4 | 2016 | 39 | 0.300 |
Why?
| | Ophthalmic Artery | 2 | 2018 | 5 | 0.300 |
Why?
| | Foramen Magnum | 2 | 2021 | 9 | 0.300 |
Why?
| | Brain Mapping | 5 | 2020 | 521 | 0.300 |
Why?
| | Brain Neoplasms | 1 | 2015 | 966 | 0.290 |
Why?
| | Cerebral Revascularization | 2 | 2020 | 15 | 0.280 |
Why?
| | Cohort Studies | 11 | 2023 | 4883 | 0.270 |
Why?
| | Child | 24 | 2023 | 18401 | 0.260 |
Why?
| | Risk Factors | 8 | 2022 | 8614 | 0.260 |
Why?
| | Antineoplastic Agents, Alkylating | 2 | 2018 | 68 | 0.250 |
Why?
| | Young Adult | 15 | 2022 | 10444 | 0.250 |
Why?
| | Preoperative Care | 3 | 2021 | 319 | 0.250 |
Why?
| | Sclerosing Solutions | 3 | 2022 | 9 | 0.250 |
Why?
| | Infant | 13 | 2023 | 7943 | 0.250 |
Why?
| | Meningioma | 2 | 2016 | 76 | 0.240 |
Why?
| | Embolectomy | 2 | 2017 | 11 | 0.240 |
Why?
| | Mutation | 5 | 2021 | 3338 | 0.240 |
Why?
| | Catheterization | 2 | 2017 | 158 | 0.240 |
Why?
| | Intracranial Arteriosclerosis | 2 | 2014 | 8 | 0.230 |
Why?
| | Perfusion Imaging | 3 | 2022 | 51 | 0.230 |
Why?
| | Mosaicism | 2 | 2021 | 62 | 0.230 |
Why?
| | Imaging, Three-Dimensional | 3 | 2020 | 511 | 0.220 |
Why?
| | Adolescent | 21 | 2023 | 17800 | 0.220 |
Why?
| | Radiography | 4 | 2014 | 803 | 0.220 |
Why?
| | Microsurgery | 2 | 2021 | 58 | 0.220 |
Why?
| | Child, Preschool | 15 | 2021 | 9114 | 0.220 |
Why?
| | Computed Tomography Angiography | 3 | 2020 | 100 | 0.220 |
Why?
| | Swine | 6 | 2018 | 687 | 0.210 |
Why?
| | Neurosurgical Procedures | 5 | 2022 | 150 | 0.210 |
Why?
| | Cerebral Cortex | 3 | 2022 | 380 | 0.210 |
Why?
| | Radiology, Interventional | 1 | 2023 | 26 | 0.210 |
Why?
| | Flow Cytometry | 2 | 2017 | 1075 | 0.200 |
Why?
| | Ventriculostomy | 2 | 2013 | 17 | 0.190 |
Why?
| | Giant Cell Arteritis | 1 | 2022 | 48 | 0.190 |
Why?
| | Methamphetamine | 1 | 2022 | 51 | 0.190 |
Why?
| | Actins | 2 | 2013 | 376 | 0.190 |
Why?
| | Polyarteritis Nodosa | 1 | 2021 | 5 | 0.190 |
Why?
| | Combined Modality Therapy | 3 | 2016 | 1117 | 0.190 |
Why?
| | Hematoma | 1 | 2021 | 50 | 0.190 |
Why?
| | Materials Testing | 2 | 2020 | 337 | 0.190 |
Why?
| | Phenotype | 5 | 2021 | 2784 | 0.190 |
Why?
| | Cerebrovascular Disorders | 1 | 2022 | 82 | 0.190 |
Why?
| | Angioplasty, Balloon | 1 | 2022 | 89 | 0.180 |
Why?
| | Surgery, Computer-Assisted | 2 | 2019 | 61 | 0.180 |
Why?
| | Gene Expression | 2 | 2017 | 1417 | 0.180 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 25 | 0.180 |
Why?
| | Iodine Compounds | 1 | 2020 | 2 | 0.180 |
Why?
| | Moyamoya Disease | 1 | 2020 | 14 | 0.180 |
Why?
| | Equipment Design | 5 | 2015 | 503 | 0.180 |
Why?
| | Recurrence | 3 | 2020 | 925 | 0.180 |
Why?
| | Brain Infarction | 1 | 2020 | 22 | 0.180 |
Why?
| | Calcium Channel Blockers | 2 | 2022 | 113 | 0.180 |
Why?
| | Orbit | 2 | 2011 | 52 | 0.180 |
Why?
| | Growth Disorders | 1 | 2021 | 77 | 0.180 |
Why?
| | Nervous System Diseases | 2 | 2021 | 254 | 0.180 |
Why?
| | Spinal Cord Diseases | 1 | 2020 | 38 | 0.180 |
Why?
| | Blood Vessels | 1 | 2022 | 179 | 0.170 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 2 | 2011 | 75 | 0.170 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2020 | 10 | 0.170 |
Why?
| | Models, Anatomic | 1 | 2020 | 86 | 0.170 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 61 | 0.170 |
Why?
| | Head Injuries, Penetrating | 1 | 2020 | 7 | 0.170 |
Why?
| | Unconsciousness | 1 | 2020 | 18 | 0.170 |
Why?
| | Drug Administration Schedule | 1 | 2022 | 714 | 0.170 |
Why?
| | Pyrimidinones | 1 | 2020 | 88 | 0.170 |
Why?
| | Observer Variation | 1 | 2020 | 298 | 0.170 |
Why?
| | Follow-Up Studies | 8 | 2021 | 4392 | 0.170 |
Why?
| | Multivariate Analysis | 2 | 2020 | 1422 | 0.170 |
Why?
| | Aspirin | 1 | 2022 | 324 | 0.160 |
Why?
| | Pyridones | 1 | 2020 | 122 | 0.160 |
Why?
| | Torticollis | 1 | 2019 | 12 | 0.160 |
Why?
| | Amnesia | 1 | 2019 | 42 | 0.160 |
Why?
| | Models, Neurological | 1 | 2021 | 212 | 0.160 |
Why?
| | Polyvinyls | 2 | 2016 | 17 | 0.160 |
Why?
| | Brain Stem | 1 | 2020 | 94 | 0.160 |
Why?
| | Cerebral Infarction | 2 | 2022 | 39 | 0.160 |
Why?
| | Pitch Perception | 1 | 2019 | 8 | 0.160 |
Why?
| | Behavioral Symptoms | 1 | 2019 | 41 | 0.160 |
Why?
| | Dimethyl Sulfoxide | 2 | 2016 | 42 | 0.160 |
Why?
| | Postoperative Hemorrhage | 1 | 2019 | 74 | 0.160 |
Why?
| | Blood Flow Velocity | 2 | 2017 | 388 | 0.160 |
Why?
| | Migraine Disorders | 1 | 2020 | 82 | 0.160 |
Why?
| | Blood-Brain Barrier | 1 | 2019 | 106 | 0.150 |
Why?
| | Reproducibility of Results | 4 | 2020 | 2764 | 0.150 |
Why?
| | Rabbits | 2 | 2022 | 733 | 0.150 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2019 | 496 | 0.150 |
Why?
| | Vascular Patency | 1 | 2018 | 97 | 0.150 |
Why?
| | Family Health | 1 | 2019 | 193 | 0.150 |
Why?
| | Plaque, Atherosclerotic | 1 | 2019 | 46 | 0.150 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1331 | 0.150 |
Why?
| | Cell Count | 1 | 2019 | 303 | 0.150 |
Why?
| | Motivation | 1 | 2022 | 488 | 0.150 |
Why?
| | Retinal Vein | 1 | 2018 | 13 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2021 | 233 | 0.150 |
Why?
| | Infant, Newborn | 8 | 2023 | 5038 | 0.150 |
Why?
| | Depression | 3 | 2022 | 1133 | 0.150 |
Why?
| | Receptor, TIE-1 | 1 | 2017 | 1 | 0.150 |
Why?
| | Memory | 1 | 2019 | 209 | 0.150 |
Why?
| | Endoglin | 1 | 2017 | 20 | 0.150 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 414 | 0.140 |
Why?
| | von Willebrand Factor | 1 | 2017 | 55 | 0.140 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2017 | 56 | 0.140 |
Why?
| | Diagnostic Errors | 1 | 2018 | 150 | 0.140 |
Why?
| | Gyrus Cinguli | 1 | 2017 | 70 | 0.140 |
Why?
| | Cochlear Implantation | 1 | 2019 | 79 | 0.140 |
Why?
| | Phlebography | 1 | 2017 | 35 | 0.140 |
Why?
| | Cochlear Implants | 1 | 2019 | 93 | 0.140 |
Why?
| | Retinal Diseases | 1 | 2018 | 76 | 0.140 |
Why?
| | Radiographic Image Enhancement | 1 | 2017 | 52 | 0.140 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2017 | 83 | 0.140 |
Why?
| | Conscious Sedation | 1 | 2017 | 78 | 0.140 |
Why?
| | Mental Health | 1 | 2022 | 559 | 0.140 |
Why?
| | Microvessels | 1 | 2017 | 66 | 0.140 |
Why?
| | Workflow | 1 | 2017 | 132 | 0.140 |
Why?
| | Thalamus | 1 | 2017 | 74 | 0.140 |
Why?
| | Prospective Studies | 7 | 2021 | 6195 | 0.130 |
Why?
| | Time-to-Treatment | 1 | 2017 | 146 | 0.130 |
Why?
| | Depressive Disorder | 1 | 2019 | 330 | 0.130 |
Why?
| | Health Care Costs | 1 | 2019 | 381 | 0.130 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 1875 | 0.130 |
Why?
| | Carotid Arteries | 1 | 2017 | 180 | 0.130 |
Why?
| | Time Factors | 3 | 2022 | 6077 | 0.130 |
Why?
| | Renal Artery | 1 | 2016 | 26 | 0.130 |
Why?
| | Meningeal Arteries | 1 | 2015 | 1 | 0.130 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1518 | 0.130 |
Why?
| | Tantalum | 1 | 2015 | 3 | 0.130 |
Why?
| | Ferrous Compounds | 1 | 2015 | 22 | 0.130 |
Why?
| | Magnets | 1 | 2015 | 15 | 0.130 |
Why?
| | American Heart Association | 1 | 2017 | 264 | 0.130 |
Why?
| | Hematoma, Subdural, Intracranial | 1 | 2015 | 1 | 0.130 |
Why?
| | Hemodynamics | 2 | 2017 | 1015 | 0.130 |
Why?
| | Filtration | 1 | 2015 | 57 | 0.130 |
Why?
| | Hearing Loss | 1 | 2019 | 183 | 0.130 |
Why?
| | Meningeal Neoplasms | 1 | 2016 | 86 | 0.130 |
Why?
| | Ferric Compounds | 1 | 2015 | 41 | 0.120 |
Why?
| | Genotype | 1 | 2020 | 1757 | 0.120 |
Why?
| | Aneurysm, False | 1 | 2015 | 45 | 0.120 |
Why?
| | Collateral Circulation | 1 | 2015 | 18 | 0.120 |
Why?
| | Laser Capture Microdissection | 1 | 2014 | 23 | 0.120 |
Why?
| | Biopsy, Needle | 1 | 2015 | 180 | 0.120 |
Why?
| | Drug Carriers | 1 | 2015 | 112 | 0.120 |
Why?
| | Intracranial Hypertension | 1 | 2015 | 36 | 0.120 |
Why?
| | Prefrontal Cortex | 1 | 2017 | 263 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 784 | 0.120 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 117 | 0.120 |
Why?
| | Lasers | 1 | 2015 | 121 | 0.120 |
Why?
| | Decision Making | 1 | 2021 | 760 | 0.120 |
Why?
| | Severity of Illness Index | 1 | 2022 | 2537 | 0.120 |
Why?
| | Vein of Galen Malformations | 1 | 2014 | 2 | 0.120 |
Why?
| | Depressive Disorder, Major | 1 | 2017 | 301 | 0.120 |
Why?
| | DNA, Complementary | 1 | 2014 | 255 | 0.120 |
Why?
| | Magnetic Phenomena | 1 | 2014 | 9 | 0.110 |
Why?
| | Recovery of Function | 1 | 2018 | 573 | 0.110 |
Why?
| | Reference Values | 1 | 2015 | 739 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 314 | 0.110 |
Why?
| | Skin | 2 | 2017 | 653 | 0.110 |
Why?
| | Cerebral Arterial Diseases | 1 | 2013 | 42 | 0.110 |
Why?
| | Optical Imaging | 1 | 2014 | 52 | 0.110 |
Why?
| | Prognosis | 6 | 2017 | 3315 | 0.110 |
Why?
| | Animals | 9 | 2022 | 31565 | 0.110 |
Why?
| | Artifacts | 1 | 2014 | 114 | 0.110 |
Why?
| | Tungsten | 1 | 2013 | 27 | 0.110 |
Why?
| | Equipment Failure Analysis | 1 | 2013 | 132 | 0.110 |
Why?
| | Alloys | 1 | 2013 | 30 | 0.110 |
Why?
| | Electrocardiography | 1 | 1996 | 561 | 0.100 |
Why?
| | Ketones | 1 | 2013 | 44 | 0.100 |
Why?
| | Neck | 2 | 2023 | 85 | 0.100 |
Why?
| | Intracranial Thrombosis | 1 | 2012 | 17 | 0.100 |
Why?
| | Comorbidity | 2 | 2014 | 1447 | 0.100 |
Why?
| | Radiation Dosage | 1 | 2014 | 133 | 0.100 |
Why?
| | Carboxypeptidases | 1 | 1992 | 12 | 0.100 |
Why?
| | Paresis | 1 | 2012 | 28 | 0.100 |
Why?
| | Aorta, Abdominal | 1 | 2012 | 39 | 0.100 |
Why?
| | Health Personnel | 1 | 2017 | 569 | 0.100 |
Why?
| | Zygoma | 1 | 2011 | 11 | 0.100 |
Why?
| | Serine Endopeptidases | 1 | 1992 | 101 | 0.100 |
Why?
| | Proteoglycans | 1 | 1992 | 107 | 0.090 |
Why?
| | Parents | 1 | 2019 | 1181 | 0.090 |
Why?
| | Cells, Cultured | 2 | 2022 | 3861 | 0.090 |
Why?
| | Hot Temperature | 1 | 2013 | 301 | 0.090 |
Why?
| | Ethanol | 1 | 2015 | 534 | 0.090 |
Why?
| | Cranial Sinuses | 2 | 2021 | 12 | 0.090 |
Why?
| | Peptide Hydrolases | 1 | 1992 | 103 | 0.090 |
Why?
| | Mast Cells | 1 | 1992 | 116 | 0.090 |
Why?
| | Predictive Value of Tests | 4 | 2020 | 1791 | 0.090 |
Why?
| | Quality of Life | 1 | 2022 | 2343 | 0.090 |
Why?
| | Patient Admission | 1 | 2012 | 175 | 0.090 |
Why?
| | Cell Survival | 1 | 2013 | 1014 | 0.090 |
Why?
| | Cerebral Ventriculography | 1 | 2010 | 3 | 0.090 |
Why?
| | Angiography | 3 | 2018 | 176 | 0.090 |
Why?
| | Echoencephalography | 1 | 2010 | 4 | 0.090 |
Why?
| | Organotechnetium Compounds | 1 | 2010 | 10 | 0.090 |
Why?
| | Cerebral Ventricles | 1 | 2010 | 47 | 0.090 |
Why?
| | Spinal Neoplasms | 1 | 2009 | 26 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2322 | 0.080 |
Why?
| | Datasets as Topic | 2 | 2020 | 98 | 0.080 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2022 | 409 | 0.080 |
Why?
| | Hydrocephalus | 1 | 2010 | 83 | 0.080 |
Why?
| | Myocardial Infarction | 1 | 1996 | 932 | 0.080 |
Why?
| | Emergency Medical Services | 1 | 1996 | 581 | 0.080 |
Why?
| | RNA | 1 | 2014 | 806 | 0.080 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2019 | 684 | 0.080 |
Why?
| | Cysteine | 1 | 2010 | 171 | 0.080 |
Why?
| | Polyethylene Glycols | 1 | 2013 | 561 | 0.080 |
Why?
| | ROC Curve | 2 | 2022 | 441 | 0.080 |
Why?
| | Constriction, Pathologic | 2 | 2022 | 207 | 0.070 |
Why?
| | Rupture | 2 | 2020 | 96 | 0.070 |
Why?
| | Arteries | 2 | 2022 | 246 | 0.070 |
Why?
| | Sensitivity and Specificity | 3 | 2020 | 1690 | 0.070 |
Why?
| | Brain Injuries | 1 | 2013 | 459 | 0.070 |
Why?
| | Registries | 1 | 2015 | 1764 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2019 | 3003 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2015 | 3498 | 0.070 |
Why?
| | Injections, Intra-Arterial | 2 | 2015 | 25 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 4595 | 0.060 |
Why?
| | Regional Blood Flow | 2 | 2018 | 421 | 0.060 |
Why?
| | Hypertension | 1 | 2012 | 1052 | 0.060 |
Why?
| | Age Distribution | 2 | 2014 | 341 | 0.060 |
Why?
| | Models, Animal | 2 | 2016 | 340 | 0.050 |
Why?
| | Doxycycline | 1 | 2022 | 54 | 0.050 |
Why?
| | Age Factors | 2 | 2021 | 2885 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 4402 | 0.050 |
Why?
| | Head | 1 | 2022 | 85 | 0.050 |
Why?
| | Pericytes | 1 | 2022 | 24 | 0.050 |
Why?
| | Technology | 1 | 2022 | 78 | 0.050 |
Why?
| | Sodium | 1 | 2022 | 184 | 0.050 |
Why?
| | Mood Disorders | 1 | 2022 | 112 | 0.050 |
Why?
| | Aging, Premature | 1 | 2021 | 11 | 0.050 |
Why?
| | Skin Abnormalities | 1 | 2021 | 10 | 0.050 |
Why?
| | Intraoperative Period | 1 | 2021 | 51 | 0.050 |
Why?
| | Intention | 1 | 2022 | 142 | 0.050 |
Why?
| | Survival Rate | 2 | 2014 | 1638 | 0.050 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 71 | 0.050 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2021 | 154 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 186 | 0.040 |
Why?
| | Canada | 1 | 2021 | 320 | 0.040 |
Why?
| | Headache | 1 | 2021 | 132 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2021 | 131 | 0.040 |
Why?
| | Vietnam Conflict | 1 | 2020 | 3 | 0.040 |
Why?
| | Models, Theoretical | 2 | 2014 | 513 | 0.040 |
Why?
| | Coma | 1 | 2020 | 30 | 0.040 |
Why?
| | Propensity Score | 1 | 2021 | 225 | 0.040 |
Why?
| | Fibroblasts | 2 | 2022 | 834 | 0.040 |
Why?
| | Visual Cortex | 1 | 2020 | 41 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 444 | 0.040 |
Why?
| | Behavior Observation Techniques | 1 | 2019 | 9 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 330 | 0.040 |
Why?
| | Defense Mechanisms | 1 | 2019 | 24 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 2022 | 304 | 0.040 |
Why?
| | Corneal Edema | 1 | 1999 | 3 | 0.040 |
Why?
| | Gray Matter | 1 | 2020 | 67 | 0.040 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 1999 | 17 | 0.040 |
Why?
| | Refractive Errors | 1 | 1999 | 13 | 0.040 |
Why?
| | Endothelium, Corneal | 1 | 1999 | 15 | 0.040 |
Why?
| | Diplopia | 1 | 2019 | 15 | 0.040 |
Why?
| | Monocytes | 1 | 2022 | 503 | 0.040 |
Why?
| | Postoperative Complications | 2 | 2021 | 2122 | 0.040 |
Why?
| | Basal Ganglia | 1 | 2019 | 44 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2019 | 196 | 0.040 |
Why?
| | Machine Learning | 1 | 2022 | 315 | 0.040 |
Why?
| | Cranial Nerve Diseases | 1 | 2019 | 42 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 57 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2020 | 452 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 990 | 0.040 |
Why?
| | Thiophenes | 1 | 1999 | 108 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2019 | 119 | 0.040 |
Why?
| | Problem Behavior | 1 | 2019 | 86 | 0.040 |
Why?
| | Hemorrhage | 1 | 2022 | 600 | 0.040 |
Why?
| | Paracentesis | 1 | 2018 | 6 | 0.040 |
Why?
| | Polytetrafluoroethylene | 1 | 1998 | 25 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 1998 | 19 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 437 | 0.040 |
Why?
| | Anterior Cerebral Artery | 1 | 2017 | 5 | 0.040 |
Why?
| | Groin | 1 | 2017 | 13 | 0.040 |
Why?
| | Punctures | 1 | 2017 | 36 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 295 | 0.040 |
Why?
| | Speech Perception | 1 | 2019 | 73 | 0.040 |
Why?
| | United States | 3 | 2021 | 12137 | 0.040 |
Why?
| | Middle Cerebral Artery | 1 | 2017 | 36 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 2018 | 198 | 0.040 |
Why?
| | Cerebellum | 1 | 2019 | 199 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 328 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2021 | 641 | 0.030 |
Why?
| | Parent-Child Relations | 1 | 2019 | 235 | 0.030 |
Why?
| | Carotid Artery, External | 1 | 2016 | 3 | 0.030 |
Why?
| | Prostheses and Implants | 1 | 1998 | 135 | 0.030 |
Why?
| | Blood Volume | 1 | 2016 | 57 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 1981 | 0.030 |
Why?
| | Genetic Variation | 1 | 2021 | 868 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2384 | 0.030 |
Why?
| | Gray Platelet Syndrome | 1 | 2015 | 3 | 0.030 |
Why?
| | Fibrous Dysplasia, Polyostotic | 1 | 2015 | 7 | 0.030 |
Why?
| | Dexamethasone | 1 | 2018 | 316 | 0.030 |
Why?
| | Venous Pressure | 1 | 2015 | 8 | 0.030 |
Why?
| | Sulfonamides | 1 | 1999 | 444 | 0.030 |
Why?
| | Image Enhancement | 1 | 2016 | 158 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2017 | 481 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2016 | 332 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 843 | 0.030 |
Why?
| | Drug Compounding | 1 | 2015 | 89 | 0.030 |
Why?
| | Confidence Intervals | 1 | 1996 | 302 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2247 | 0.030 |
Why?
| | Sex Distribution | 1 | 1996 | 336 | 0.030 |
Why?
| | Diffusion | 1 | 2015 | 119 | 0.030 |
Why?
| | Perfusion | 1 | 2015 | 147 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1350 | 0.030 |
Why?
| | Particle Size | 1 | 2015 | 317 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2015 | 179 | 0.030 |
Why?
| | Multimodal Imaging | 1 | 2015 | 89 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2015 | 291 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 926 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 1998 | 372 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2019 | 442 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1310 | 0.030 |
Why?
| | Mydriasis | 1 | 2013 | 8 | 0.030 |
Why?
| | Causality | 1 | 2014 | 104 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2018 | 526 | 0.030 |
Why?
| | Electromagnetic Radiation | 1 | 2013 | 2 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2014 | 285 | 0.030 |
Why?
| | Benzophenones | 1 | 2013 | 16 | 0.030 |
Why?
| | Oxygen | 1 | 2017 | 851 | 0.030 |
Why?
| | Analysis of Variance | 1 | 1996 | 1218 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 261 | 0.030 |
Why?
| | Cervical Vertebrae | 1 | 2013 | 104 | 0.030 |
Why?
| | California | 1 | 2014 | 351 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2090 | 0.030 |
Why?
| | Chymases | 1 | 1992 | 3 | 0.030 |
Why?
| | Chromatography, Affinity | 1 | 1992 | 80 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 1992 | 122 | 0.020 |
Why?
| | Molecular Weight | 1 | 1992 | 328 | 0.020 |
Why?
| | Exocytosis | 1 | 1992 | 89 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2464 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1360 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 5499 | 0.020 |
Why?
| | Polymers | 1 | 2013 | 448 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2009 | 82 | 0.020 |
Why?
| | Veterans | 1 | 2020 | 1248 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 4501 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2371 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2314 | 0.020 |
Why?
| | Carcinoma, Renal Cell | 1 | 2009 | 168 | 0.020 |
Why?
| | Databases, Factual | 1 | 2012 | 1125 | 0.020 |
Why?
| | Kidney Neoplasms | 1 | 2009 | 324 | 0.020 |
Why?
| | Keratoplasty, Penetrating | 1 | 1999 | 4 | 0.010 |
Why?
| | Administration, Topical | 1 | 1999 | 137 | 0.010 |
Why?
| | Ophthalmic Solutions | 1 | 1999 | 66 | 0.010 |
Why?
| | Swine, Miniature | 1 | 1998 | 70 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1998 | 167 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 107 | 0.010 |
Why?
| | Visual Acuity | 1 | 1999 | 272 | 0.010 |
Why?
| | Intraocular Pressure | 1 | 1999 | 275 | 0.010 |
Why?
| | Surface Properties | 1 | 1998 | 385 | 0.010 |
Why?
| | Lymphocytes | 1 | 1998 | 327 | 0.010 |
Why?
| | Glaucoma | 1 | 1999 | 201 | 0.010 |
Why?
| | Surgical Wound Infection | 1 | 1998 | 246 | 0.010 |
Why?
| | Neutrophils | 1 | 1998 | 1089 | 0.010 |
Why?
|
|
Cooke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|